- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00931593
Transient Lower Esophageal Sphincter Relaxations and High Resolution Manometry
Transient Lower Esophageal Sphincter Relaxations Detection Using High Resolution Manometry. Validation in Healthy Volunteers.
Transient lower esophageal sphincter relaxations (tLESr) are the main mechanism of gastro-oesophageal reflux disease. They occur without any deglutition in patients but also in healthy volunteers. They are induced by meal.
The gold standard to detect tLESr is esophageal manometry using perfused Dentsleeve probe.
Esophageal high resolution manometry with solid state sensors was developed in the 90s. The examination is easier and more accurate than perfused manometry. The aim of this study is to validate in healthy volunteers the use of high resolution manometry (Sierra Scientific Instruments, California CA) to detect tLESr.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33075
- Not yet recruiting
- Hôpital St André, CHU BORDEAUX
-
Contact:
- ZERBIB Frank, MD
- Phone Number: 05 56 79 58 06
- Email: frank.zerbib@chu-bordeaux.fr
-
Principal Investigator:
- ZERBIB Frank, MD
-
Lyon, France, 69437
- Recruiting
- Hôpital Edouard Herriot - Hospices Civils de Lyon
-
Contact:
- ROMAN Sabine
- Phone Number: 04 72 11 01 36
- Email: sabine.roman@chu-lyon.fr
-
Principal Investigator:
- ROMAN Sabine, MD
-
Sub-Investigator:
- MION François, MD
-
Nantes, France, 44093
- Not yet recruiting
- Hôpital Hôtel Dieu, CHU NANTES
-
Contact:
- BRULEY DES VARANNES Stanislas, MD
- Phone Number: 02 40 08 31 65
-
Principal Investigator:
- BRULEY DE VARANNES Stanislas, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or Female between 18 and 60 years
- Subject without typical or atypical symptoms of gastro-esophageal reflux disease (heartburn, regurgitation, epigastric pain, chest pain, chronic cough, pharyngeal pain)
- Subject without any medication (except oral contraception)
- Subject without previous digestive surgery history (except appendicectomy)
- Capability to pass manometric probes through each nostril
- Subject with health insurance
- Written informed consent
- No participation to another study at the same time
Exclusion Criteria:
- Age under 18 years or upper 60
- Pregnant woman or lactation
- Incapability to give consent
- No written informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: volunteers
This is a descriptive study to compare two techniques (manometry with perfused dentsleeve probe vs high resolution manometry for the identification of tLESr). Each subject is his own control. The date of perfused manometry is randomized to avoid bias due to examinations' order. |
Visit V0 (day 0 - 2 to 14 days):
Visit V1 (day 0):
Visit V2 (day 0 + 1 day): Phone contact Visit V3 (day 0 + 2 to 7 days):
Visit V4 (V3 + 1 day): Phone contact and end of the study |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
The primary outcome is to demonstrate that high resolution manometry allows the detection of meal-induced tLESr. All recordings will be analyzed at the end of each examination and reviewed at the end of the enrolment.
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
To compare the number of tLESr detected by high resolution manometry and those detected by manometry with perfused dentsleeve probe.
|
|
To define the characteristics (duration, relaxation amplitude) of high resolution manometry-detected tLESr.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: ROMAN Sabine, MD, Hospices Civils de Lyon
- Principal Investigator: MION François, MD, Hospices Civils de Lyon
- Principal Investigator: BRULEY DES VARANNES Stanislas, MD, CHRU Nantes
- Principal Investigator: ZERBIB Frank, MD, Chru Bordeaux
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2008.546/47
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.